Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK ( TheStreet) -- On a special edition of his "Mad Money" TV show Friday, Jim Cramer saluted our troops by hosting a live studio audience of men and women who are serving or have served in our military.

He said today's rally shows what happens when good news is treated as good news and not as a reason to fear the Federal Reserve.

Cramer also laid out his game plan for next week's trading.

Monday, he'll be watching the Chinese industrial production numbers, along with the initial public offering of children's apparel Web site Zulily.

On Tuesday, Cramer said he'll be watching the health care conference that may bring news from Bristol-Myers Squibb ( BMY) and Johnson & Johnson ( JNJ).

Next, on Wednesday, it's earnings from AFC Enterprises ( AFCE), purveyors of Popeye's restaurants, along with network equipment maker Cisco ( CSCO), which he said will be the most controversial conference call of the week as the tech sector remains in flux.

Lots of retail earnings on Thursday, said Cramer, including Wal-Mart ( WMT), Kohl's ( KSS) and Nordstrom ( JWN). Cramer said he expects a good holiday for all with higher employment and lower gasoline prices. Another plus on Thursday will be Viacom ( VIAB), the media giant with a giant stock buyback that is actually making a difference.

Finally, on Friday, Cramer said the U.S. industrial production numbers will be in the spotlight and he's looking for more good news that the domestic economy continues to stir.

Executive Decision: Don Knauss

In the "Executive Decision" segment, Cramer sat down on location with Don Knauss, chairman and CEO of Clorox ( CLX), as they celebrated the second annual Kingsford Invitational Grilling Competition, with all proceeds benefiting veterans.

Knauss, himself a Marine Corps veteran, said that 15% of Clorox's hires in 2013 were veterans, and veterans make excellent employees for Clorox thanks to the fact they're mission-oriented, work well in teams and have a maturity and work ethic that's rivaled by none.

Turning to the business of Clorox, Knauss said he's challenged every brand in the company to innovate around health and wellness, sustainability, affordability and multi-cultural areas, and every brand has responded in at least one area. Even a business as mature as bleach is seeing sales up 14% when it would typically rise only 1% to 2% in line with inflation.

If you liked this article you might like

Bristol-Myers Squibb Stock Still a Beast?

There Are Good Opportunities in Stock Picking

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

Achillion Shares Are Plunging on Termination of Hepatitis C Pact